Thursday, July 19, 2012

Could Breaking Up Be J&J's Salvation? - July 19, 2012

Having trouble viewing this email? View in Browser.
Deals & Dollars
   Thursday, July 19, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Pharmaceutical & Healthcare Marketing MBA Program for Executives

The Executive programs in Pharmaceutical & Healthcare Marketing at Saint Joseph's University are ideal for working professionals in the pharma, biotech, medical device, diagnostics and healthcare sectors. Our Classroom model combines the convenience of Friday/Saturday classes with pre- and post-assignments. Our Online students complete a course each month and participate in 3-4 multi-day residencies. Perfect for those who travel, may be transferred/promoted, and who need access from anywhere across North America and beyond.

Please click here for more information.
HeadHtml
•  Could Breaking Up Be Johnson & Johnson (JNJ)'s Salvation? More...
More Industry News
HeadHtml
•  Skyepharma PLC (SKYEF) Invests £5 Million, Added 40 New Jobs in Sanofi (France) (SAN.PA) Site to Produce Asthma Inhaler More...
•  BioRamo Gets Incentives for 36 Fort Lauderdale Jobs More...
More Job Industry News
HeadHtml
•   Agile Therapeutics, Inc. Raises $40 Million in a Series C Financing More...
•   The Franklin Institute Receives $2.5 Million Gift From Teva Pharmaceutical Industries Limited (TEVA) More...
•   Novasep Invests £3 Million to Boost its HPAPI Manufacturing Capabilities More...
More Finance News
Events

BioContact Quebec
October 3 - 4, 2012
Chateau Laurier Quebec 1220 Place

Biopharmaceutical partnership symposium that is expecting more than 500 participants representing all sectors of the industry. namely biopharmaceutical and pharmaceutical companies, universities, venture capital, consulting and governmental organizations.

For more information, please visit: www.biocontact.ca.

The Life Sciences Report: 6 Biotech Stocks Riding the Baby Boomer Wave
By Diane Alter, Money Morning

"While no one has discovered a cure for Alzheimer's, cancer, Parkinson's or other ailments that come along with old age, several biotech companies are racing to cure a long list of diseases and disorders. The prospects are daunting but the possibilities in the biotech field are literally endless, for patients and investors alike." More...
 
HeadHtml
•   Guardian Point Asks Sun Pharmaceutical Industries Ltd to Up Taro Pharmaceutical Industries Ltd. (TARO) Offer More...
•   Chengdu Hoist Selling Animal Health Business More...
•   Nestle Health Science Takes Stake in Accera, Inc. to Advance Potential of Axona® More...
•   SAIC's $473 Million Aquisition to More than Double Commercial Health Care Business More...
More Mergers and Acquisitions News
HeadHtml
•   Purdue Pharma L.P. Ends Infinity Pharmaceuticals Inc. (INFI) Partnership, Buys $27.5 Million in Stock More...
•   Array BioPharma, Inc. (ARRY) Reaches $8.5 Million Milestone in Amgen (AMGN) Diabetes Agreement More...
•   Thermo Fisher Scientific (TMO) and Refine Technology Partner for Expanded Capabilities More...
•   Life Technologies (LIFE) Signs Collaborative Agreement With Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies More...
•   PAREXEL International (PRXL) and Korea Drug Development Fund Announce Alliance to Accelerate Global Drug Development and Commercialization More...
More Alliances News

•   DARA BioSciences, Inc. Names Stephen Jaeger to Board More...
•   DBV Technologies Welcomes Mr. Stef Koppelman as Its New General Scientific Advisor More...
•   Drs. Bruce Rosengard and Sanuj Ravindran Join The Medicines Company (MDCO) New Business Ventures Team More...

More Personnel News
Tower: Facebook
HeadHtml
•   Novartis AG (NVS) Banks on New Drugs to Offset Generics Pressure More...
•   Cost Cuts Help Actelion Ltd. (ALIOF.PK) Lift Earnings View More...
•   Abbott Laboratories (ABT) 2Q Profit Beats Expectations as Humira Sales Grow More...
•   Athersys, Inc. to Host Second Quarter 2012 Financial Results Call More...
•   AMAG Pharmaceuticals, Inc. (AMAG) to Host Conference Call on July 26, 2012 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended June 30, 2012 More...
More Earnings Report News
HeadHtml
•   Johnson & Johnson (JNJ) Escapes Class Action Suit Over Recalls More...
•   Somaxon Pharmaceuticals, Inc. (SOMX) Announces Settlement of Silenor Patent Litigation With Zydus Pharmaceuticals (USA) Inc. More...
•   Pfizer Inc. (PFE) Wins Price Fixing Case in Indonesia More...
More Legal News
HeadHtml
•   Verenium Corporation (VRNM) and Alexandria Real Estate Equities, Inc. Celebrate the Grand Opening of a New State-of-the-art Biotechnology Facility More...
•   Acorda Therapeutics (ACOR) Relocates Corporate Headquarters to Ardsley Park Life Science Campus More...
•   Renascions Moves into Janssen Labs More...
More Construction News
 
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
Real Estate



Florida Turbine Building Available
100 Marquette Drive
Jupiter, Florida U.S.A

Building Size: 188,000 sq ft
Number of Floors: 1
Parking Ratio: 4 per 1000 sq ft

More Real Estate Listings
Feature

Hot Company

Celera Corporation
1401 Harbor Bay Parkway
Alameda, California 94502 U.S.A.
Phone: 510-749-4200

Celera Corporation, acquired by Quest Diagnostics in May 2011, is a healthcare business that uses knowledge of human variability to provide new tests and services to personalize disease management. Our Products business develops and manufactures molecular diagnostic products that are used by hospitals and other clinical laboratories to detect, characterize, monitor and select treatment for disease.

More Company Profiles
Top Jobs
Biotech Beach (Culver City, California)

Novo Nordisk, Inc.
Pharma Field Sales - Diabetes Care Specialist
Assume responsibility for achieving sales goals by implementing marketing and sales strategies aimed at effectively selling and promoting Novo Nordisk's portfolio of diabetes products to physicians, pharmacists, nurses, and other paramedical customers and current co-promotion partners who make or are involved in purchasing and prescribing decisions.

Southern Pharm (Columbia, Georgia)

Takeda Pharmaceuticals
Sales Representative
Responsible for selling the Takeda family of products. This will be achieved through clinical discussions with targeted health professionals to maximize sales growth and increase product volume within a specific geography.

Genetown (Billerica, Massachusetts)

454 Life Sciences - division of Roche
Chemicals Product Manager
Responsible for driving the development of all Lab Essentials business within a defined product portfolio / segment in NA in line with the global strategy. Responsible for development and implementation of NA marketing plan forthe defined portfolio together with the sales team. Contributingto the global marketing strategy by working with the global product management and segment teams to fully exploit global synergies, and gain support for NA specific needs, for the market segment.

Pharm Country (Woodcliff Lake, New Jersey)

Eisai Inc.
Director, Product Marketing, Epilepsy Franchise
Will provide commercial input into IPT/GLT meetings and clinical development plan documents. Additionally, we'll ask that you create and deliver clear direction when building strong relationships with internal cross-functional colleagues as well external partners and customers.

Biotech Bay (Santa Clara, California)

Affymetrix
Marketing Manager
will be accountable for product management and business activities pertaining to the relevant portfolio including, but not limited to, strategic product management and portfolio positioning of existing products, collaboration development, product and platform positioning, and marketing communication strategy.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!
Career Fairs

2012 Pharm Country Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Pharm Country Career Fair, Bridgewater, NJ September 13, 2012
Biotech Beach Career Fair, San Diego, CA September 20, 2012
Biotech Bay Career Fair, Burlingame, CA October 3, 2012
BioCapital Career Fair, Bethesda, MD October 9, 2012
BioMidwest Career Fair, Lincolnshire, IL October 22, 2012
Bio NC Career Fair, Durham, NC October 25, 2012
Genetown Career Fair, Cambridge, MA November 5, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace, Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace, Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe

If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.
 


No comments: